In addition, viral shedding is reduced in the CP group in critically/severe patients with respiratory failure in non-early stages of the disease, the duration of illness is significantly shorter, and hospital discharges show a positive trend in patients who received CP therapy [ 26 ].
← all excerpts
Convalescent Plasma Therapy, Therapeutic Formulations of Repurposed Drugs in 20th Century Epidemics against COVID-19: A Systematic Review.
2
—
—
The sentences
This study identified and summarized six RCTs that showed a decreasing trend in the period of infection, symptomatology and mortality related to SARS-CoV-2 infection, with no serious adverse effects associated with CP therapy.